An interventional study of Educational Intervention in Prostate, sponsored by Sidney Kimmel Cancer Center at Thomas Jefferson University. Terminated. Open to male participants. Per ClinicalTrials.gov, last updated 2025-05-02.
Sponsored by Sidney Kimmel Cancer Center at Thomas Jefferson University · Not applicable, Interventional, and Supportive care
This pilot clinical trial studies a virtual reality education module in reducing anxiety and increasing knowledge in patients with prostate cancer undergoing radiation therapy. A virtual reality education module may be useful in helping patients understand what they can expect to happen during their radiation treatments and help reduce stress relating to the radiation treatments.
PRIMARY OBJECTIVES:
I. To determine if a virtual reality education module for prostate cancer patients is effective in increasing patient comprehension and decreasing patient anxiety related to radiation treatments.
SECONDARY OBJECTIVES:
I. This pilot study could have implications for a broader patient base undergoing radiation therapy.
Exclusion Criteria:
After undergoing a previously planned CT simulation scan, patients complete a virtual reality education module to learn more about radiation therapy for prostate cancer. Patients also complete questionnaires before and after the module.
Other: Educational Intervention
Complete virtual reality education module
Standard deviation for difference in questionnaire response from pre-education to post-education
A one-sided one-sample t-test will be used to analyze the average change score (pre - post) for each questionnaire.
Time frame: Through study completion, an average of 2 years
No study locations are listed for this record.
Plan to share: Undecided
This study is terminated, as verified in May 2025. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Sidney Kimmel Cancer Center at Thomas Jefferson University